Medidata Solutions Inc (MDSO) Holdings Reduced by S&CO Inc.

S&CO Inc. lessened its position in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 58.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,500 shares of the company’s stock after selling 5,000 shares during the quarter. S&CO Inc.’s holdings in Medidata Solutions were worth $257,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Janus Henderson Group PLC raised its stake in shares of Medidata Solutions by 69.7% during the 2nd quarter. Janus Henderson Group PLC now owns 1,904,094 shares of the company’s stock worth $153,394,000 after buying an additional 782,194 shares during the last quarter. American Century Companies Inc. raised its stake in shares of Medidata Solutions by 6.5% during the 3rd quarter. American Century Companies Inc. now owns 1,592,367 shares of the company’s stock worth $116,736,000 after buying an additional 97,571 shares during the last quarter. Canada Pension Plan Investment Board raised its stake in shares of Medidata Solutions by 2.8% during the 2nd quarter. Canada Pension Plan Investment Board now owns 1,111,500 shares of the company’s stock worth $89,542,000 after buying an additional 29,800 shares during the last quarter. Fred Alger Management Inc. raised its stake in shares of Medidata Solutions by 87.3% during the 2nd quarter. Fred Alger Management Inc. now owns 1,068,170 shares of the company’s stock worth $86,052,000 after buying an additional 497,817 shares during the last quarter. Finally, Northern Trust Corp raised its stake in shares of Medidata Solutions by 3.0% during the 2nd quarter. Northern Trust Corp now owns 921,165 shares of the company’s stock worth $74,210,000 after buying an additional 26,469 shares during the last quarter.

Medidata Solutions stock opened at $72.82 on Thursday. The stock has a market cap of $4.44 billion, a P/E ratio of 85.66, a P/E/G ratio of 4.28 and a beta of 1.30. Medidata Solutions Inc has a 52 week low of $59.60 and a 52 week high of $88.87. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.52 and a quick ratio of 2.52.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings data on Thursday, October 18th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.06. The firm had revenue of $163.41 million during the quarter, compared to analysts’ expectations of $162.09 million. Medidata Solutions had a return on equity of 10.70% and a net margin of 8.43%. The firm’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.33 EPS. As a group, sell-side analysts forecast that Medidata Solutions Inc will post 0.85 earnings per share for the current year.

MDSO has been the subject of several research reports. Royal Bank of Canada raised Medidata Solutions from a “sector perform” rating to an “outperform” rating and set a $100.00 price target for the company in a research note on Tuesday, July 17th. JPMorgan Chase & Co. downgraded Medidata Solutions from an “overweight” rating to a “neutral” rating and set a $87.00 price target for the company. in a research note on Tuesday, July 24th. ValuEngine downgraded Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday, July 24th. Needham & Company LLC downgraded Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, July 25th. Finally, Morgan Stanley set a $84.00 price target on Medidata Solutions and gave the stock a “hold” rating in a research note on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $84.64.

In related news, EVP Michael I. Otner sold 7,030 shares of Medidata Solutions stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $69.40, for a total transaction of $487,882.00. Following the completion of the sale, the executive vice president now owns 62,548 shares in the company, valued at approximately $4,340,831.20. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 4.70% of the company’s stock.

WARNING: This report was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.wkrb13.com/2018/11/08/medidata-solutions-inc-mdso-holdings-reduced-by-sco-inc.html.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

See Also: Market Capitalization in the Stock Market

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply